Racial differences in treatment patterns and outcomes of first-line (1L) therapies for advanced renal cell carcinoma (aRCC) in the real-world (RW) setting.

被引：0

作者：

Geynisman, Daniel M.

Kish, Jonathan K.

Falkenstein, Angelica

Huo, Stephen

Del Tejo, Viviana

Rosenblatt, Lisa

Guttenplan, Sarah

Balanean, Alexandrina

Feinberg, Bruce A.

机构：

[1] Fox Chase Canc Ctr, Philadelphia, PA USA

[2] Cardinal Hlth, Dublin, OH USA

[3] Cardinal Hlth Specialty Solut, Dublin, OH USA

[4] Bristol Myers Squibb, Princeton, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4548

引用

页数：1